The First Ever Marijuana-Based Prescription Drug Could Soon Hit The Market

For years, scientists studying seizure disorders have observed the powerful effects of cannabidiol (CBD) on difficult-to-treat seizure disorders like Dravet Syndrome and epilepsy.

Animal studies have shown CBD, found naturally in cannabis, consistently prevent convulsions - and, according to the American Epilepsy Society, anecdotal evidence suggests it's also highly effective in children with hard-to-treat types of epilepsy.

According to a small study of 19 children whose parents treated their seizures using so-called artisanal CBD preparations, like concentrates and edibles.

"Sixteen (84%) of the 19 parents reported a reduction in their child's seizure frequency while taking CBD. Of these, two (11%) reported complete seizure freedom, eight (42%) reported a greater than 80% reduction in seizure frequency, and six (32%) reported a 25–60% seizure reduction. Results from this study for CBD treatment are displayed in the graphs below:

Enter the experimental drug Epidolex. The CBD-based drug developed by GW Pharmaceuticals is designed to control seizures. It's a purified formula of cannabinoid CBD, meaning no more guesswork in terms of dosage, and a reliable product for parents already treating their children's seizure disorders with CBD.

If Epidolex wins FDA approval, it'll be a first in the U.S. While drugs like Nabilone and Dronabinol approximate delta-9 THC - the principal cannabinoid of marijuana - those preparations are entirely synthetic. Epidolex would be the first prescription drug sold in modern America actually derived from the plant.

GW Pharmaceuticals remains in talks with the Food and Drug Administration to get Epidolex approved for use in the United States.


President Trump's 2020 budget request includes a loophole that would let Washington, DC finally open up dispensaries for recreational cannabis. Although DC voters passed a ballot initiative to legalize recreational cannabis back in 2014, Congress has used its power over the nation's capital to prevent it from selling cannabis for recreational use. Right now, local dispensaries can only sell medical marijuana to registered patients thanks to Congress, which controls spending in the District of Columbia.

Can we see some ID please?

You must be 19 years of age or older to enter.